Choline produces antiarrhythmic actions in animal models by cardiac M 3 receptors: Improvement of intracellular Ca2+ handling as a common mechanism

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 12, 2008, Pages 860-865

  Liu, Yan ^a   Sun, Hong Li ^a   Li, Dan Lu ^a   Wang, Li Yan ^a   Gao, Yang ^a   Wang, Yu Ping ^a   Du, Zhi Min ^a   Lu, Yan Jie ^a,b   Yang, Bao Feng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Key Laboratory   (China)

Author keywords

4 DAMP; Aconitine; Arrhythmias; Ca 2+; Choline; M3 receptor; Ouabain

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CALCIUM; CALCIUM CHANNEL L TYPE; CHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART PROTECTION; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WISTAR RAT;

ACONITINE; ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CHOLINE; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; MALE; MYOCYTES, CARDIAC; OUABAIN; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M3;

EID: 57349155598     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-094     Document Type: Article

References (15)

1. De Jesus Moreno Moreno, M. 2003. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 25(1): 178-193. doi:10.1016/S0149-2918(03)90023-3. PMID:12637119.
2. + currents densities in ventricular myocytes of guinea pigs by chronic oxidant stress. Acta Pharmacol. Sin. 25(6): 751-755. PMID: 15169627.
3. 2+ homeostasis in the cardiac excitation-contraction coupling is a crucial mechanism of arrhythmic toxicity in aconitine-induced cardiomyocytes. Biochem. Biophys. Res. Commun. 354(4): 929-936. doi:10.1016/j.bbrc.2007.01.082. PMID:17276394.
4. Gong, D.M., Shan, H.L., Zhou, Y.H., Dong, D.L., and Yang, B.F. 2004. The ion targets of arrhythmias induced by ouabain and aconitine in guinea pig and rat ventricular myocytes. Acta Pharmacol. Sin. 39(5): 328-332.
5. Haubrich, D.R., and Pflueger, A.B. 1979. Choline administration: central effect mediated by stimulation of acetylcholine synthesis. Life Sci. 24(12): 1083-1090. doi:10.1016/0024-3205(79)90041-9. PMID:449608.
6. 2-induced apoptosis of rat myocardial cells in vitro. Acta Pharmacol. Sin. 39(11): 887-891.
7. 3)-a new target of antiarrhythmic agents. Acta Pharmacol. Sin. 40(1): 8-12.
8. Mest, H.J., and Forster, W. 1979. The central nervous effect of prostaglandins I2, E2 and F2 alpha on aconitine-induced cardiac arrhythmia in rats. Prostaglandins, 18(2): 235-239. doi:10.1016/0090-6980(79)90108-4. PMID:392624.
9. Moroz, V.M., and Lipnitskii, T.N. 2006. Dysfunction of ionic channels in cardiomyocyte sarcolemma and cardiac arrhythmias. Bull. Exp. Biol. Med. 141(4): 397-399. doi:10.1007/s10517-006-0181-5. PMID:17152353.
10. Podzuweit, T. 1982. Cyclic AMP arrhythmias. Inhibition by choline esters. Adv. Myocardiol. 3: 193-198. PMID:6302763.
11. Sun, H.L., Chu, W.F., Dong, D.L., Liu, Y., Bai, Y.L., Wang, X.H., et al. 2006. Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in guinea pig. Basic Clin. Pharmacol. Toxicol. 98(4): 381-388. doi:10.1111/j.1742-7843.2006.pto_319.x. PMID:16623862.
12. Wada, K., Nihira, M., Hayakawa, H., Tomita, Y., Hayashida, M., and Ohno, Y. 2005. Effects of long-term administrations of aconitine on electrocardiogram and tissue concentrations of aconitine and its metabolites in mice. Forensic Sci. Int. 148(1): 21-29. doi:10.1016/j.forsciint.2004.04.016. PMID:15607586.
13. 3 subtype muscarinic acetylcholine receptors. Cell. Physiol. Biochem. 16(4-6): 163-174. doi:10.1159/000089842. PMID:16301817.
14. Yang, B.F., Lin, H.X., Xiao, J.N., Lu, Y., Luo, X.B., Li, B.X., et al. 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13(4): 486-491. doi:10.1038/nm1569. PMID:17401374.
15. 3-mAChR) in ventricle myocytes. Cell. Physiol. Biochem. 17(3-4): 129-136. doi:10.1159/ 000092074. PMID:16543729.